ADAGIO THERAPEUTICS INC (ADGI)

US00534A1025 - Common Stock

4.64  +0.04 (+0.87%)

After market: 4.52 -0.12 (-2.59%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-6-30)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.00
Operating Expenses
296.00M226.91M65.33M
Research and Development
246.96M190.39M62.12M
Selling, General, and Administrative Expenses
49.04M36.52M3.21M
Operating Income
-296.00M-226.91M-65.33M
Interest Income/Expense
1.87M1.70M8.00K
Other Income/Expense
-945.00K-1.58MN/A
Income Before Taxes
-295.07M-226.79M-65.32M
Net Income
-295.07M-226.79M-65.32M
EBITDA
N/A-226.91MN/A
 
Per Share Data
EPS Diluted Total Ops
-3.15-5.32-0.60
Non GAAP EPS
-3.15N/AN/A
 
Statistics

All data in USD

Charts